Company Monitoring Page for Merck

latest headlines for company on cafepharma

Top Merck executive to depart company for CEO role at ingredients maker

BioPharma Dive

Thu, 01/20/22 - 11:26 pm

Tags:

Merck, Frank Clyburn, IFF

Merck scores a win in $1.4B insurance fight over devastating cyberattack

Fierce Pharma

Thu, 01/20/22 - 10:50 am

Tags:

Merck, cybersecurity, cyberattack, insurance

Almost three years after whiffing in a confirmatory study, Merck touts new data for Keytruda in HCC

Endpoints

Wed, 01/19/22 - 10:59 am

Tags:

Merck, Keytruda, liver cancer, HCC

The top 10 biopharma M&A deals in 2021

Fierce Pharma

Tue, 01/18/22 - 10:53 am

Biotech investors pray for a takeover miracle

EP Vantage

Fri, 01/14/22 - 11:09 am

Tags:

M&A, biotech, Amylyx Pharmaceuticals, Arena Pharmaceuticals, AstraZeneca, Aurinia Pharmaceuticals, Biogen, Biohaven, Bristol Myers Squibb, Eli Lilly, GSK, Merck, Novartis, Novo Nordisk, Pfizer, Sanofi

Chasing Roche, Merck unveils adjuvant lung cancer data for Keytruda

Pharmaforum

Tue, 01/11/22 - 11:28 am

Tags:

Merck, Roche, Keytruda, clinical trials, non-small cell lung cancer, Tecentriq

Idorsia scores FDA go-ahead for insomnia drug Quviviq to rival Merck’s Belsomra, Eisai’s Dayvigo

Fierce Pharma

Mon, 01/10/22 - 11:37 pm

Tags:

Idorsia, Quviviq, insomnia, FDA, Merck, Belsomra

Atea sticks it out with failed COVID-19 antiviral but also raids Merck's store room for hepatitis C drug

Fierce Biotech

Fri, 01/7/22 - 10:47 am

Tags:

Atea Pharmaceuticals, antivirals, COVID-19, Merck, bemnifosbuvir.

Merck, putting $150M on the table, doubles down on pledge tackle maternal mortality and health inequities

Fierce Pharma

Fri, 01/7/22 - 10:35 am

Tags:

Merck, maternal health, Women's Health

Merck KGaA buys manufacturer of key component in mRNA medicines

BioPharma Dive

Thu, 01/6/22 - 12:37 pm

Tags:

Merck, KGaA, MRNA, M&A, Exelead

Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pill

Reuters

Tue, 01/4/22 - 10:46 pm

Tags:

Dr Reddy's, Merck, generics, COVID-19, molnupiravir

Biopharma developments over the Christmas period

EP Vantage

Mon, 01/3/22 - 10:26 am

Tags:

Alnylam Pharmaceuticals, Bio-Thera Solutions, BioArctic, Biogen, BridgeBio Pharma, Daiichi Sankyo, Eisai, JNJ, Madrigal Pharmaceuticals, Merck, Sutro BioPharma, Tasly Pharmaceutical Group

France Rejects Merck's COVID-19 Pill: How Bad Is the News?

Motley Fool

Sun, 01/2/22 - 11:39 pm

Tags:

Merck, COVID-19, molnupiravir, France

FDA authorizes Merck’s Covid-19 pill, but stresses its use should be limited

Stat

Thu, 12/23/21 - 12:03 pm

Tags:

FDA, Merck, molnupiravir, COVID-19

Efficacy of Pfizer's Covid pill holds up in final analysis, reducing risk of hospitalization or death by almost 90%

Endpoints

Tue, 12/14/21 - 11:21 am

Tags:

Pfizer, Paxlovid, clinical trials, COVID-19, antivirals, Merck

Merck’s Covid Pill Might Pose Risks for Pregnant Women

NY Times, NY

Mon, 12/13/21 - 11:52 pm

Tags:

Merck, COVID-19, molnupiravir, pregnancy, DNA

Bellus soars on positive mid-stage readout for its Merck cough rival, despite a failure in atopic dermatitis

Endpoints

Mon, 12/13/21 - 11:06 am

Tags:

Bellus Health, chronic cough, Merck, BLU-5937, gefapixant

Why an FDA Panel Had Concerns About Merck's COVID-19 Pill

Motley Fool

Sat, 12/11/21 - 09:26 pm

Tags:

Merck, COVID-19, FDA, molnupiravir

Merck pauses 2 more trials of backbone HIV drug over red flag, raising doubts about multipronged R&D strategy

Fierce Biotech

Tue, 12/7/21 - 10:43 am

Tags:

Merck, HIV, clinical trials, MK-8507

Immuno-oncology spotlight falls on cervical cancer

EP Vantage

Tue, 12/7/21 - 10:39 am

Tags:

immuno-oncology, cervical cancer, Opdivo, Keytruda, Bristol Myers Squibb, Merck

Company Monitoring Page for Merck

latest headlines for company on cafepharma

Pages

last 30 twitter posts

current feelings about your job

Search form

You are here

Company Monitoring Page for Merck

latest headlines for company on cafepharma

Pages

last 30 twitter posts

current feelings about your job